Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Tessa Romero
JPM
Tessa Romero
J.P. Morgan
Wall Street Analyst
★★☆☆☆
#1990
on 13Foresight · ranked by our own returns
35%
Success Rate
-1.4%
Average Return
8 of 23 calls profitable · -10.2% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 35% of Tessa Romero's ratings turned a profit when each position was held for 1 year — averaging -1.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

57 Buy 15 Hold 5 Sell
Tessa's Stock Coverage 23 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
UPB
Upstream Bio, Inc.
 Jun 12, 2026 HOLD Strong Buy
+514.9% avg upside
9 analysts
$8.00
28.06% Upside
 ·
NRIX
Nurix Therapeutics
 Jun 11, 2026 BUY Strong Buy
+75.6% avg upside
26 analysts
 — ·
AGIO
Agios Pharma
 Jun 11, 2026 HOLD Strong Buy
+73.2% avg upside
29 analysts
$31.00
9.29% Downside
 ·
SPTX
Seaport Therapeutics, Inc.
 Jun 08, 2026 BUY Strong Buy
+95.4% avg upside
4 analysts
$42.00
131.23% Upside
 ·
EWTX
Edgewise Therapeutics
 Jun 05, 2026 BUY Strong Buy
+22.4% avg upside
14 analysts
$53.00
44.04% Upside
 -4.6%
CYTK
Cytokinetics
 Jun 05, 2026 BUY Strong Buy
+8.9% avg upside
36 analysts
$97.00
23.15% Upside
 +10.5%
OCS
Oculis Holding
 Jun 03, 2026 BUY Strong Buy
+241.9% avg upside
11 analysts
$23.00
104.89% Upside
 -14.0%
XENE
Xenon
 May 27, 2026 BUY Strong Buy
+19.0% avg upside
28 analysts
$82.00
54.97% Upside
 -2.8%
LRMR
Larimar Therapeutics
 May 27, 2026 BUY Strong Buy
+409.3% avg upside
21 analysts
$9.00
147.21% Upside
 -3.4%
NMRA
Neumora Therapeutics, Inc.
 May 26, 2026 SELL Buy
+422.4% avg upside
11 analysts
 — ·
SRRK
Scholar Rock Holding
 May 08, 2026 BUY Strong Buy
+20.1% avg upside
23 analysts
$56.00
18.37% Upside
 -3.0%
RCKT
Rocket Pharmaceuticals
 Apr 02, 2026 SELL Buy
+393.7% avg upside
29 analysts
 — +16.6%
SEPN
Septerna, Inc.
 Mar 24, 2026 BUY Strong Buy
+18.2% avg upside
12 analysts
$38.00
5.00% Upside
 +29.8%
DYN
Dyne Therapeutics
 Mar 16, 2026 HOLD Strong Buy
+92.7% avg upside
29 analysts
$16.00
19.12% Downside
 +9.2%
EYPT
EyePoint Pharmaceuticals
 Mar 10, 2026 BUY Strong Buy
+123.7% avg upside
17 analysts
$33.00
143.06% Upside
 -14.8%
ACAD
ACADIA Pharmaceuticals
 Mar 04, 2026 BUY Strong Buy
+65.9% avg upside
42 analysts
$34.00
57.31% Upside
 -7.6%
BHVN
Biohaven Ltd.
 Dec 26, 2025 BUY Strong Buy
+87.5% avg upside
25 analysts
 — +21.7%
PRME
Prime Medicine, Inc.
 Nov 18, 2025 HOLD Strong Buy
+209.6% avg upside
16 analysts
 — -13.8%
LXEO
Lexeo Therapeutics, Inc.
 Oct 07, 2025 BUY Strong Buy
+313.8% avg upside
11 analysts
 — -39.0%
MCRB
Seres Therapeutics
 Oct 23, 2024 SELL Buy
+162.2% avg upside
10 analysts
 — -17.1%
SANA
Sana Biotechnology
 Oct 18, 2024 HOLD Strong Buy
+214.8% avg upside
14 analysts
 — +18.9%
ATRA
Atara Biotherapeutics
 Jul 13, 2022 HOLD Buy
+79.6% avg upside
18 analysts
$10.00
0.74% Downside
 -48.8%
RIGL
Rigel
 Nov 09, 2020 HOLD Strong Buy
-27.5% avg upside
17 analysts
 — +24.9%
🔒 18 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Tessa Romero — Frequently Asked Questions
How accurate are Tessa Romero's stock ratings?
Based on the calls 13Foresight could measure, about 35% of Tessa's ratings were profitable over a one-year hold, with an average return of -1.4% per rating, or -10.2% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Tessa ranked on 13Foresight?
Tessa Romero is currently ranked #1990 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Tessa cover?
Tessa most recently has ratings on UPB, NRIX, AGIO, SPTX, EWTX, CYTK, OCS, XENE, LRMR, NMRA, SRRK, RCKT and 11 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.